gliclazide has been researched along with Coronary Artery Disease in 2 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, M | 1 |
| Li, LZ | 1 |
| Jiang, ZA | 1 |
| Li, LH | 1 |
| Feng, YG | 1 |
| Fu, XH | 1 |
| O'Brien, RC | 1 |
| Luo, M | 1 |
2 other studies available for gliclazide and Coronary Artery Disease
| Article | Year |
|---|---|
[Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease].
Topics: Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mel | 2017 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus | 1997 |